Title page
Type of the study: Case report
Title: Tyrosine kinase inhibitor-induced severe bullous
pemphigoid in a patient with advanced stage of liver cancer: a case
report and literature review
Authors: Li Y1,2, Wang
M1,2, Wang TT1,2*
1Author affiliations Department of Dermatology, West
China Hospital, Sichuan University, Chengdu, 610041, China
2Laboratory of Dermatology, Clinical Institute of
Inflammation and Immunology, Frontiers Science Center for
Disease-related Molecular Network, West China Hospital, Sichuan
University, Chengdu, 610041, China
* Correspondence: Department of Dermatology, West China
Hospital, Sichuan University, Chengdu, 610041, China. Email:
wangtingting817@126.com
Ethics statement: All appropriate informed consent forms were
obtained from the patient’s parent. The patient’s parent gave written
informed consent for publication of the report details and associated
photographs. Institutional approval was not required to publish the case
details.
Conflict of interest: None.
Financial support: None.
Author contributions: LY and WTT designed the study and
acquired, analyzed, and interpreted the data. LY wrote the manuscript.
WTT and WM critically revised the manuscript for important intellectual
content. All authors have contributed to the manuscript and approved the
submitted version.
Tyrosine kinase inhibitor-induced severe bullous pemphigoid in a patient
with advanced stage of liver cancer: a case report and literature review
Yu Li1, Mi Wang1,2, Tingting
Wang1,2
1Author affiliations Department of Dermatology, West
China Hospital, Sichuan University, Chengdu, 610041, China
2Laboratory of Dermatology, Clinical Institute of
Inflammation and Immunology, Frontiers Science Center for
Disease-related Molecular Network, West China Hospital, Sichuan
University, Chengdu, 610041, China
Correspondence: Tingting Wang
Department of Dermatology, West China Hospital, Sichuan University,
Chengdu, 610041, China. Email: wangtingting817@126.com